Patents Assigned to SUZHOU JI ER BIOLOGICAL MEDICINE CO., LTD.
  • Patent number: 11866458
    Abstract: The invention discloses a panaxadiol glycoside derivative and a preparation method and application thereof. Such compounds show strong anti-inflammatory effects in vitro and in animal model experiments, and thus can be used to prepare anti-inflammatory drugs, especially can be used for treating asthma and COPD. In the experiment, the above-mentioned compounds have obvious effects on asthma and COPD, and the efficacy of the high-dose group is superior than that of dexamethasone and budesonide. Even under the dose much exceeding the therapeutic dose, no obvious affect on blood routine and blood glucoseis observed. It has high industrial prospects in the field of anti-inflammatory drugs, especially in the field for treating asthma and COPD.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: January 9, 2024
    Assignee: Suzhou JI ER Biological Medicine Co. Ltd.
    Inventors: Quanhai Liu, Jun Zhang
  • Publication number: 20210054019
    Abstract: The invention discloses a panaxadiol glycoside derivative and a preparation method and application thereof. Such compounds show strong anti-inflammatory effects in vitro and in animal model experiments, and thus can be used to prepare anti-inflammatory drugs, especially can be used for treating asthma and COPD. In the experiment, the above-mentioned compounds have obvious effects on asthma and COPD, and the efficacy of the high-dose group is superior than that of dexamethasone and budesonide. Even under the dose much exceeding the therapeutic dose, no obvious affect on blood routine and blood glucoseis observed. It has high industrial prospects in the field of anti-inflammatory drugs, especially in the field for treating asthma and COPD.
    Type: Application
    Filed: July 15, 2019
    Publication date: February 25, 2021
    Applicant: SUZHOU JI ER BIOLOGICAL MEDICINE CO., LTD.
    Inventors: QUANHAI LIU, JUN ZHANG